Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ZK-EPO reported highly effective in a breast cancer bone metastasis model

March 19, 2007

Anticancer compounds disclosed in recent patent literature

March 19, 2007

TG-1042 for cutaneous B-cell lymphoma in phase II trial

March 16, 2007

Tragara closes Series A financing to support oncology and inflammatory programs

March 16, 2007

Nektar advances PEG-irinotecan into phase I

March 16, 2007

Curis selects CUDC-101 from targeted cancer drug development platform

March 16, 2007

Adherex outlines achievements of 2006, updates goals for 2007

March 16, 2007

Recent patents cover new therapeutic agents for cancer

March 16, 2007

Astellas Pharma updates clinical progress of YM-155

March 16, 2007

SPA agreement for phase III EOquin trials in noninvasive bladder cancer

March 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...